OpenAlex
PricingAboutJobs
Log inGet started
Work

Phase III trial of lenalidomide plus high-dose dexamethasone versus lenalidomide plus low-dose dexamethasone in newly diagnosed multiple myeloma (E4A03): A trial coordinated by the Eastern Cooperative Oncology Group

HTML

Year: 2007
Type: conference-abstract
Source: Journal of Clinical Oncology
DOI: 10.1200/jco.2007.25.18_suppl.lba8025
Authors: S. V. Rajkumar, S. Jacobus, N. Callander, R. Fonseca, D. Vesole, M. Williams, R. Abonour, D. Siegel, P. Greipp
Institutions: Hackensack University Medical Center, Mayo Clinic, University of Wisconsin–Madison, Saint Vincent's Catholic Medical Center, Dana-Farber Cancer Institute, Indiana University Indianapolis, University of Virginia
Language: English

Topic: Multiple Myeloma Research and Treatments
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Keywords: lenalidomide, dexamethasone, newly diagnosed multiple myeloma, high-dose dexamethasone, low-dose dexamethasone, combination chemotherapy, overall survival, response rate, thromboembolism, drug toxicity, Eastern Cooperative Oncology Group, interim analysis, non-hematologic toxicity, hyperglycemia
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W1867927052
Cites:
Cited by: 145
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms
Security